Events
-
-
ABGSC Life Science Summit
Ascelia Pharma presents at ABG Sundal Collier Life Science Summit. The seminar will be a webinar.
-
ABGSC Life Science Summit
Ascelia Pharma presents at ABG Sundal Collier Life Science Summit. The seminar will be a webinar.
-
Redeye Orphan Drugs conference
Haymarket by Scandic Hötorget 13-15, Stockholm, SwedenAscelia Pharma presents at Redeye's Orphan Drug event.
-
Redeye Orphan Drugs conference
Haymarket by Scandic Hötorget 13-15, Stockholm, SwedenAscelia Pharma presents at Redeye's Orphan Drug event.
-
-
Half-year financial report 2020 (Jan-Jun)
Report will be released at 8.00am CET and conference call at 10.00 am CET. Link to info about conference call/webcast: https://financialhearings.com/event/12527
-
Half-year financial report 2020 (Jan-Jun)
Report will be released at 8.00am CET and conference call at 10.00 am CET. Link to info about conference call/webcast: https://financialhearings.com/event/12527
-
-
LSX Nordic congress 2020
CEO Magnus Corfitzen presents at the annual LSX Nordic congress. Link to the agenda of the congress is found here: https://www.lsxleaders.com/hubfs/378634/LSX%20Nordic%20Congress%202020%20Brochure.pdf
-
LSX Nordic congress 2020
CEO Magnus Corfitzen presents at the annual LSX Nordic congress. Link to the agenda of the congress is found here: https://www.lsxleaders.com/hubfs/378634/LSX%20Nordic%20Congress%202020%20Brochure.pdf
-
Pareto Securities’ Healthcare conference
Ascelia Pharma presents at Pareto Securities' Healthcare conference.
-
Pareto Securities’ Healthcare conference
Ascelia Pharma presents at Pareto Securities' Healthcare conference.
-
Aktiedagen (event with Swedish Shareholders’ Association)
Ascelia Pharma's Project Director Andreas Norlin presents at the Swedish Shareholders Association's event Aktiedagen. The presentation is streamed and can be followed online. See more information here: https://www.aktiespararna.se/aktiviteter/aktiedagen-digitalt-15-september
-
Aktiedagen (event with Swedish Shareholders’ Association)
Ascelia Pharma's Project Director Andreas Norlin presents at the Swedish Shareholders Association's event Aktiedagen. The presentation is streamed and can be followed online. See more information here: https://www.aktiespararna.se/aktiviteter/aktiedagen-digitalt-15-september
-
Økonomisk Ugebrev Life Science Investor Meeting, Copenhagen
Symbion Fruebjergvej 3 Fruebjergvej, Copenhagen, DenmarkAscelia Pharma's CEO Magnus Corfitzen presents at Økonomisk Ugebrev Life Science Investor Meeting in Copenhagen.
-
Økonomisk Ugebrev Life Science Investor Meeting, Copenhagen
Symbion Fruebjergvej 3 Fruebjergvej, Copenhagen, DenmarkAscelia Pharma's CEO Magnus Corfitzen presents at Økonomisk Ugebrev Life Science Investor Meeting in Copenhagen.
-
-
Capital Markets Day (virtual event)
Live Q&A webcast The virtual event consists of presentations from Ascelia Pharma executives followed by a live Q&A webcast. The presentations will be available on Ascelia Pharma’s website: https://www.ascelia.com/capital-markets-day-2020/ The livestreamed Q&A webcast will take place on October 21 from 14:00-15:00 CET. A recording of the Q&A webcast will be published on Ascelia Pharma’s […]
-
Capital Markets Day (virtual event)
Live Q&A webcast The virtual event consists of presentations from Ascelia Pharma executives followed by a live Q&A webcast. The presentations will be available on Ascelia Pharma’s website: https://www.ascelia.com/capital-markets-day-2020/ The livestreamed Q&A webcast will take place on October 21 from 14:00-15:00 CET. A recording of the Q&A webcast will be published on Ascelia Pharma’s […]
-
-
Interim financial report 9M 2020 (Jan-Sep)
Report will be released at 8.00am CET and conference call at 10.00 am CET. Webcast: https://tv.streamfabriken.com/ascelia-pharma-q3-2020 Teleconference - Dial-in numbers: SE: +46 8 505 583 53 UK: +44 333 300 9265 US: +1 833 823 0590 DK: +45 781 501 07
-
Interim financial report 9M 2020 (Jan-Sep)
Report will be released at 8.00am CET and conference call at 10.00 am CET. Webcast: https://tv.streamfabriken.com/ascelia-pharma-q3-2020 Teleconference - Dial-in numbers: SE: +46 8 505 583 53 UK: +44 333 300 9265 US: +1 833 823 0590 DK: +45 781 501 07